Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07890038) titled 'The Clinical Application Value of CAIX-Targeted PET Hypoxia Imaging in Malignant Tumors' on Oct. 16.
Study Type: Observational
Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Condition:
Nasopharyngeal Cancers
Lung Cancer (NSCLC)
Esophageal Cancer
Glioma
Intervention:
Diagnostic Test: Specific PET Imaging Agent Targeting CAIX
Recruitment Status: Not recruiting
Date of First Enrollment: June 11, 2026
Target Sample Size: 50
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07890038
Disclaimer: Curated by HT Syndicati...